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Abstract
Background
The prevalence ofWuchereria bancrofti, which causes lymphatic filariasis (LF) in The Gam-
bia was among the highest in Africa in the 1950s. However, surveys conducted in 1975 and
1976 revealed a dramatic decline in LF endemicity in the absence of mass drug administra-
tion (MDA). The decline in prevalence was partly attributed to a significant reduction in mos-
quito density through the widespread use of insecticidal nets. Based on findings elsewhere
that vector control alone can interrupt LF, we asked the question in 2013 whether the rapid
scale up in the use of insecticidal nets in The Gambia had interrupted LF transmission.
Methodology/Principal Finding
We present here the results of three independently designed filariasis surveys conducted
over a period of 17 years (1997–2013), and involving over 6000 subjects in 21 districts
across all administrative divisions in The Gambia. An immunochromatographic (ICT) test
was used to detectW. bancrofti antigen during all three surveys. In 2001, tests performed
on stored samples collected between 1997 and 2000, in three divisions, failed to show posi-
tive individuals from two divisions that were previously highly endemic for LF, suggesting a
decline towards extinction in some areas. Results of the second survey conducted in 2003
showed that LF was no longer endemic in 16 of 21 districts surveyed. The 2013 survey
used aWHO recommended LF transmission verification tool involving 3180 6–7 year-olds
attending 60 schools across the country. We demonstrated that transmission ofW. ban-
crofti has been interrupted in all 21 districts.
Conclusions
We conclude that LF transmission may have been interrupted in The Gambia through the
extensive use of insecticidal nets for malaria control for decades. The growing evidence for
the impact of malaria vector control activities on parasite transmission has been endorsed
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byWHO through a position statement in 2011 on integrated vector management to control
malaria and LF.
Author Summary
The prevalence of lymphatic filariasis (LF), in The Gambia was among the highest in Af-
rica in the 1950s when about 50% of the adult population was positive for microfilaraemia.
However, surveys conducted in 1975 and 1976 revealed a dramatic decline in LF endemici-
ty in the absence of systematic treatment with anti-filaria medicines. This decline in LF
prevalence in all villages was partly attributed to a significant drop in human-mosquito
contact through a sustained reduction in rainfall in the 1960s and 1970s and the wide-
spread use of insecticidal nets to protect against malaria. We asked the question in 2013
whether the rapid scale up in the use of insecticidal nets for malaria control in Gambia had
resulted in the interruption of LF transmission. In this paper we present the results of
three independently designed filariasis surveys conducted over a period of 17 years (1997–
2013), and involving over 6000 subjects in 21 districts across all administrative divisions in
the country. In 2001, tests performed to detect circulating filarial antigens (CFA) in serum
samples collected between 1997 and 2000, in three divisions, failed to show positive indi-
viduals from two that were previously highly endemic for the LF. Results of the second sur-
vey conducted in 2003 indicated that five of the 21 districts were slightly endemic for LF
with CFA rates of 1% or 2% but MDA was never implemented in The Gambia. The results
of our final survey conducted in 2013 were unequivocal in confirming the absence of
transmission of LF in all 21 districts surveyed using WHO recommended statistically ro-
bust and validated tool known as transmission assessment survey (TAS). The Gambia
achieving a non-endemic status for LF represents a significant step in the efforts to shrink
the filariasis endemicity map and demonstrates the value of cross sector approaches in
disease control.
Introduction
The Gambia is among 73 countries currently considered endemic for lymphatic filariasis (LF)
by the World Health Organization [1]. LF, a neglected tropical disease (NTD), is a debilitating
mosquito-borne nematode infection that affects 120 million people in low and middle income
countries where 1.4 billion people are exposed to the parasites [1].Wuchereria bancrofti, the
causative agent of LF in The Gambia, is responsible for over 90% of the LF infections world-
wide; Brugia malayi and Brugia timori account for the remaining infections and have a distri-
bution restricted to the southeast Asian region [2]. The LF parasites are carried by various
species of mosquito vectors from the genera Anopheles, Aedes, Culex andMansonia but in sub-
Saharan Africa, Anopheles species are the principal vectors[3]. There is no evidence that Culex
species play any significant role in West Africa where the malaria vectors, An. gambiae s.l and
An. funestus, are also the vectors ofW. bancrofti [3–9]. In 1997, LF was targeted for elimination
when the World Health Assembly adopted Resolution WHA 50.29 calling for the elimination
of the disease as a public health problem globally [10]. In 2000, WHO, in collaboration with
pharmaceutical companies and implementing partners launched the Global Programme to
Eliminate LF (GPELF) as a disease specific intervention initiative to interrupt transmission and
alleviate morbidity[11]. The GPELF has two strategic objectives for achieving this goal: 1)
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interruption of parasite transmission through mass drug administration (MDA) using albenda-
zole in combination with either ivermectin or diethylcarbamazine citrate (DEC) and 2) mor-
bidity management and disability prevention (MMDP) by providing access to care for those
who suffer clinical manifestations of LF in endemic areas.
By 2012, 56 of the 73 countries where LF is considered endemic had started implementing
MDA to eliminate the disease [1]. Among countries implementing MDA, only 13 countries
had completed at least five rounds of MDA and moved to post-MDA surveillance phase [1].
Nevertheless, the scale up in the use of insecticidal nets and vector control in Africa, where 17
countries including The Gambia are yet to start MDA, has significantly reduced mosquito den-
sities in many of these countries and contributed to a significant reduction in malaria preva-
lence [12, 13] and a possible decline in filariasis endemicity [3, 7, 14, 15]. In Solomon Islands
where LF was transmitted by Anophelesmosquitoes, anti-mosquito measures to control malar-
ia resulted in the interruption of LF transmission in the absence of MDA [16–18].
The Gambia had historically high prevalence of LF as described by Hawking [4, 5] in his his-
torical reviews of the distribution of filariasis in Africa where he stated that the prevalence ofW.
bancrofti among adults in the Gambia in the 1950s [19, 20] was about 50%—one of the highest
in the world. Prevalence surveys conducted in 17 villages across the country in 1975 and 1976
reported village specific microfilaraemia (MF) rates for people15 years ranging from 2.9% to
26.9%; and the apparent decline after 25 years was mainly attributed to a reduction in mosquito
density[21]. Nevertheless, MF positive children (<15 years) were present in many villages in the
Upper River, Western and Lower River divisions where LF was still highly endemic.
WHO estimates that 1.2 million people require preventive chemotherapy against LF in The
Gambia [22]. In line with the growing momentum to shrink the map of LF endemicity, we per-
formed transmission assessment surveys (TAS) in The Gambia in May and June 2013 to deter-
mine if the widespread use of insecticidal bed nets and other vector control efforts over the past
decades had eliminated transmission ofW.bancrofti in the absence of MDA [12, 14]. The in-
creasing momentum to take the “neglected” out of NTDs is driving public and private partners
including drug companies, donors, and governments committed to what is now referred to as
the 2012 London Declaration to shrink the NTD map and eliminate or eradicate by 2020 ten
NTDs including LF [23]. The commitments made to date have been centred on ensuring the
supply of drugs needed to implement preventive chemotherapy with limited emphasis on alter-
native intervention strategies such as vector control through the use of long lasting insecticidal
nets (LLINs) or indoor residual spraying. Demonstrating the interruption of active transmis-
sion ofW.bancrofti in The Gambia, in the absence of MDA, could have wide ranging public
health and policy implications with regard to alternative strategies and synergies between ma-
laria and NTD control programmes. In this paper we report the application of a newWHO
methodology, the Transmission Assessment Survey (TAS), to validate the interruption of
transmission in the absence of MDA against the disease in The Gambia after two mapping sur-
veys carried out 15 years earlier suggested a dramatic decline in LF endemicity following a
rapid decline in transmission and the possibility that elimination in the country could be
achieved. The results presented here were collected over a period of 17 years (1997–2013),
from three independently designed surveys, involving over 6000 subjects in 21 districts across
all administrative divisions in the country.
Materials and Methods
Study area
The Gambia is a country in West Africa situated on either side of the Gambia River which
flows through the country's centre and empties into the Atlantic Ocean. It lies between latitudes
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13° and 14°N, and longitudes 13° and 17°W, and stretches inland for approximately 400 km.
The Gambia is less than 48.2 km wide at its widest point, with a total area of 11,295 km2 and is
surrounded by Senegal. It is the smallest country on mainland Africa with a population of
1,882,450. The climate is typically sub-Sahelian with one short rainy season from June to Octo-
ber. The country is presently divided into eight administrative divisions, including the national
capital, Banjul. Prior to 2000, there were only 6 divisions in the country: Banjul, Western,
North Bank, Lower River, Central River and Upper River. To retain geographic context with
regard to the historical distribution of LF in The Gambia we will adhere, in this paper, with the
former administrative boundaries demarcating 6 administrative divisions as shown in Fig. 1.
Study design and blood sampling surveys
This is an observational study comparing historical prevalence from studies conducted in the
1950’s and 1970’s (Fig. 2) with 3 cross sectional surveys conducted in 2001, 2003 and 2013 ex-
amining LF infection through the distribution of circulating filarial antigen (CFA) positive in-
dividuals, involving over 6000 children and adults in 21 districts across all administrative
divisions in The Gambia.
1. In 2001, stored serum samples from people12 years residing in the previously highly en-
demic Divisions (North Bank, Upper River andWest Coast) between 1997 and 2000 were
tested for CFA. The serum/plasma samples were initially collected for malaria studies and
stored in the British Medical Research Council (MRC) Laboratories in Fajara, The Gambia.
The MRC laboratories established in The Gambia in 1947, carried out the first LF surveys in
the country in 1951 but their primary focus for research is malaria. They routinely perform
malaria surveys for several projects storing serum samples which can be processed for
other parasites.
Fig 1. Map of The Gambia showing the historical boundaries for the six administrative divisions recognised before 2000.
doi:10.1371/journal.pntd.0003642.g001
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2. In 2003, a national LF mapping survey was carried out by the Ministry of Health and Social
Welfare (MOHSW) in 30 high risk villages in all administrative divisions across the country
to determine LF distribution and endemicity, and identify implementation units eligible for
MDA. High risk communities were identified based on criteria described in the WHOman-
ual for monitoring and evaluation (M&E) of LF programs [24], including historical data on
LF, presence of diseased people and ecological suitability for mosquito breeding. MDA was,
however, never implemented as the 2003 mapping results were not presented to the WHO
Regional (African) Programme Review Group (RPRG) for review and determination of the
need for MDA. This survey was based on sampling about 100 people in each high risk vil-
lage purposely selected according to WHOmapping guidelines developed in 2000 [25].
3. In 2013, a school based TAS involving 60 randomly selected schools, was carried out as de-
scribed below, to verify the absence of transmission after the remarkable decline towards ex-
tinction in CFA rates revealed by the 2003 survey results when compared with historic data
presented in Fig. 2[21].
Transmission assessment surveys. A transmission assessment survey (TAS) protocol, de-
signed for post MDA surveys, was used in this study to determine incidence of LF in the ab-
sence of MDA and to verify the absence of transmission after the remarkable decline towards
extinction in CFA rates revealed during the 2003 survey. Molyneux and colleagues [26] dis-
cussed disease eradication, elimination and control and the need for accurate and consistent
usage and defined elimination as the reduction of incidence to zero.
The design of the TAS described in the WHOM&Emanual for national elimination pro-
grammes [24, 27], is based on lot quality assurance sampling (LQAS) with the sampling
Fig 2. Map of The Gambia showing the location andmicrofilaria (MF rates in 15 villages surveyed in 1975 and 1976 (adapted from Reference #20) in
areas of low transmission (Blue) where MF rates were less than 10% (Upper River andWestern Divisions) and high transmission (Red) where MF
rates where greater than 18% (Central River Division).
doi:10.1371/journal.pntd.0003642.g002
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method used in the evaluation units (EU) being determined by the net primary school enrol-
ment rate, the target population size and number of schools. Based on that, a random cluster
sampling was chosen with schools as the sampling sites. A Survey Sample Builder (SSB) tool
was used to determine sample size and sampling intervals. School surveys were conducted in
all divisions as the net primary enrolment rates exceeded 75% (74%-78%). All children in
grades 1 and 2 were eligible including a small proportion of those outside the 6–7 age range.
Two evaluation units (EU) were created according to LF endemicity based on historical data as
described above. The high transmission divisions of Western 1, North Bank, Lower River and
Upper River were grouped into EU1 while Banjul, Western 2 and Central River Divisions were
grouped into EU 2. Western 1 andWestern 2 were previously part of the Western Division.
The sample sizes generated by the SSB were 30 schools clusters for each EU and 1552 chil-
dren with a critical cut-off of 18 CFA positive children for the EU1 and 1556 children with a
critical cut-off of 18 for EU2. Children who had not provided assent or parental custodian
agreement, the severely sick and those who had lived in the community for less than two years
were excluded from the TAS survey.
Immunochromatographic tests (ICT) for CFA
The rapid Immunochromatographic tests (ICT) were used to test samples collected during the
three surveys described above. At the point of care, the ICT card test was performed on whole
blood or serum as described in the WHOmonitoring and impact assessment manual [24] and
following manufacturer’s instructions. The ICT cards used in 2001 and 2003 were produced by
AMRAD ICT, New South Wales, Australia[28] while the cards used for the TAS surveys in
2013 were manufactured by Binax NOW Filariasis ICT card test (Alere Inc., Scarborough,
ME). Both the AMRAD and Binax NOW ICTs were based on the same reagents and required
the same quantify of sample volume (100 μl blood/serum) for testing. A positive [28]antigen
control was used to test the validity of the ICT cards before the start of the survey in 2013.
Data entry and analysis
Data generated before 2013 was managed through a simple spread sheet that calculated per-
centages for comparative analysis. The TAS data was managed through a Microsoft Access
based data management system specifically developed by the Centre for Neglected Tropical
Diseases (CNTD) in the Liverpool School of Tropical Medicine (LSTM) to support the cluster
survey. Data entry was carried out by two independent clerks using a double entry system that
automatically compared the two entries to detect and reconcile any discrepancies. The TAS
critical cut-off value represents the threshold of infected individuals below which transmission
is expected to be no longer sustainable, even in the absence of interventions.
If the total number of positive cases is at or below the critical cut-off, the EU ‘passes’ the sur-
vey and it is considered that transmission will no longer be sustainable. If the total number of
positive cases is above the critical cut-off transmission is still ongoing in the evaluated unit[24].
TAS sample sizes and critical cut-off values are powered so that the EU has at least a 75%
chance of passing if the true antigen prevalence is half the threshold level (2% for Culex,
Anopheles, andMansonia vector areas, and 1% for Aedes vector areas). In addition, there is no
more than a 5% chance of passing if the true prevalence is greater than or equal to the
threshold level.
Ethical approval and consent procedures
Ethical clearance for the study was granted by The Medical Research Council (MRC) Laborato-
ries Gambia Scientific Coordinating Committee, the LSTM Research Ethics Committee
Elimination of Lymphatic Filariasis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003642 March 18, 2015 6 / 16
(Research Protocol (11.89R) and the Gambian Epidemiology and Disease Control Unit (EDC),
of the MOH (correspondence 23 August 2012). After approval for TAS from the Education
Ministries and school authorities, the MOHSW team met with the Head Master of each school
to obtain permission to conduct the survey and to schedule a date for meeting with the parents.
The survey team explained the purpose of the surveys and received oral consent from teachers
and parents. Non-consenting parents or non-assenting children were not included in the sur-
vey. All individuals could drop out from the study any time during the study.
Results
Historical
The results of the surveys described here are best presented in the context of the historical dis-
tribution and endemicity of LF that informed the design of the surveys carried out to determine
the pattern of LF burden and distribution in the absence of MDA. Fig. 2, adapted from the re-
sults of Knight [21] shows the burden and distribution of MF in 15 villages across five of the 6
divisions involved in this study carried out in the 1970s. Villages with MF rates of 18% or
higher were found only in the Upper River and Western divisions. The MF rates in study vil-
lages in the other divisions were lower than 10%.
Initial endemicity assessment: 1997–2000
The initial assessment of LF endemicity was carried out in the Upper River and Western Divi-
sions historically known to be highly endemic and the North bank where the MRC malaria
project was based. In 2001 a total of 268 stored serum samples collected between 1997 and
2000 from people12 years residing in three villages (Basse, Brefet, Farafenni) in the three di-
visions, were tested with ICT for the presence of CFA. CFA positive individuals (n = 8) were
only found in Basse village in the Upper River Division where 100 samples were tested. All 68
samples from Brefet (Western Division) and 100 from Farafenni (North Bank Division were
negative for CFA. Results are shown as stars in Fig. 3. The red star indicates the location of the
village where CFA positives were found in the Upper River Division.
The 8% CFA rate observed for the endemic division corresponds to between 2% and 4%MF
rate [29] indicating 89–91% reduction in MF rate over 20 years in the absence of MDA in com-
parison to the 21% (32/148) MF rates observed in the same area in 1976 by Knight [21]. The
MF rates in the Western division decreased from 15% (66/439) in 1976 to 0% (0/68) in 2000.
Nationwide mapping survey: 2003
The results of the national filariasis mapping survey conducted in 2003 are presented in Fig. 3
with circles showing the location and endemicity status of the 30 villages tested in 21 Districts
across all 6 divisions. Altogether, 3113 individuals age15 years were tested from the different
divisions: Central River (1156), Lower River (391), North Bank (682), Upper River (423) and
Western (561). CFA positive individuals were found only in 9 villages located in 5 districts out-
side the Central River Division where historically the MF rates had been low (Fig. 2). Among
the 9 villages with CFA positives, 6 were located in the Western and Upper River Divisions
where the highest MF rates were found during the 1975 and 1976 surveys (Figs 2 and 3). The
remaining three villages with CFA positives were located in the North River and Lower River
divisions not included in the historical surveys.
Elimination of Lymphatic Filariasis
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Transmission assessment surveys: 2013
In 2013, TAS was conducted in 60 randomly selected schools in all Divisions in The Gambia,
30 in each of the two EUs, to assess if active transmission ofW.bancrofti was ongoing. In total,
3180 6–7 year-old children (1509 boys and 1671 girls) were tested using ICT and none was
found to be CFA positive. 1516 children were tested in EU1 and 1664 on EU2. Fig. 4 shows the
location of schools tested during the TAS.
The changing pattern of LF infection rates determined by night blood and ICT surveys
across the 6 administrative divisions in the Gambia between 1951 and 2013 is presented in
Table 1.
Discussion
The TAS performed in this study verified the absence of transmission in all administrative divi-
sions that were previously highly endemic for LF. The prevalence ofW.bancrofti in The Gam-
bia was among the highest in Africa, based on historical data [20, 21, 30–32] and reported in
the first global atlas of LF compiled by Michael and Bundy in 1997 [33] and the African LF risk
map of Lindsay and Thomas [30]. Village specific MF rates reported in studies carried out in
the 1950s, among people 10 years or older, varied between 24.1% and 48.4% [20, 31, 32] and
Hawking[4, 5] later reported that the prevalence of LF among adults during the early 1950s
was about 50%. Based on our current knowledge of the relationship between MF rates and anti-
gen prevalence such figures suggest that the majority of adults were infected with the parasite
in the 1950’s. Night blood surveys conducted in 15 villages in 1975 and 1976 revealed MF rates
between 2.9% and 26.9% among adults15 years [21]. The corresponding high prevalence of
LF morbidity observed in children and adults in The Gambia in the 1970s confirmed that
Fig 3. The lymphatic filariasis (LF) endemicity map for The Gambia showing locations of villages where at least one of the ~100 individuals tested
during the mapping surveys was positive for CFA (Red dot or star) and villages where all ~100 tested individuals were found negative (White dot
or star). The dots and stars represent villages surveyed during 2001 and 2003 respectively.
doi:10.1371/journal.pntd.0003642.g003
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transmission had continued in the twenty years since the first surveys in the 1950s [21]. In
adults older than 15 years, morbidity presented in the form of adenolymphangitis (13.8%–
20.0%), lymphoedema (5.3%–10.0%) and hydrocele (11.7%–35.3%) [21]. Late filarial disease in
the form of elephantiasis and hydrocoele was also observed in children younger than 15 years
[21] suggesting early exposure and high levels of transmission.
A multi country operational research study undertaken in 11 EUs in Africa and Asia in
2011 and 2012, to test the value and practicality of the TAS tool, concluded that it was a practi-
cal and effective tool for evaluating interruption of transmission [27]. In 10 of 11 EUs surveyed
during the study, the number of CFA positive cases was below the critical cut-offs of 18, leading
to a cessation of MDA in these communities.
The low CFA rates (3%) observed in the previously highly endemic divisions, during the
2003 mapping surveys, therefore implies a significant reduction in MF rates in patent infection
in The Gambia between 1976 and 2003. A 9% CFA rate observed by Gass and colleagues [29]
in a highly endemic area in Ghana corresponded to a 2%MF rate. Also, previous studies have
shown that stored sera can remain antigen positive even after 10 years in storage [34]. In 2013,
all 3180 children tested during the TAS surveys were found to be negative for CFA suggesting
an interruption of the transmission ofW.bancrofti in the absence of MDA. Results of the map-
ping surveys conducted in 2003 indicated that MDA for LF was required for 5 districts where
CFA rates were 1% or higher [24]. No ‘endemic’ districts were found in the Central Division
where the intensity of transmission was historically lower [17]. MDA was however not imple-
mented by the MOHSW [1].
LF is a chronic infection perpetuated by the continuous production of microfilaria by lym-
phatic dwelling adult worms that can live for 4–6 years [35]. If competent mosquito vectors are
present in adequate numbers, transmission will continue for as long as the MF density is
Fig 4. Map of The Gambia showing the location of 60 schools surveyed during the Transmission Assessment Surveys (TAS) carried out in 2013
and revealing no circulating filarial antigen (CFA) positive individuals in all schools indicated by the white dots.
doi:10.1371/journal.pntd.0003642.g004
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maintained above a certain threshold. The host-parasite relationship inW.bancrofti transmis-
sion dynamics has been subjected to analysis using mathematical models and two infection
patterns, limitation and facilitation, have emerged depending on the vector species involved
[36–39]. Limitation, due to culicine transmitted filariasis, and facilitation, due to anopheline
vectors have been discussed in detail [3, 40–43]. The models predict that in culicine transmit-
ted-LF (limitation) the number of ingested microfilariae is always greater than the constant
predicted by a straight line proportionality relationship so that even at low MF densities para-
site uptake by mosquitoes occurs. Conversely, with anopheline-transmitted filariasis (facilita-
tion), as in The Gambia, a lower critical threshold exists below which the number of ingested
microfilariae decreases to the constant ratio. Under these conditions, transmission is not sus-
tained and the infection will be eliminated. The critical threshold below which Anopheles-
transmitted LF will be eliminated can be achieved either by reducing the density of microfilaria
or the density of mosquitoes [44]. In The Gambia, where onchocerciasis is non endemic [45],
there was never a systematic community-wide filariasis treatment that would have resulted in
the reduction ofW. bancroftiMF density [21]. The most likely explanation for our observation
that transmission has been interrupted is the reduction of vector density through the wide-
spread use of insecticide treated bednets that scaled up dramatically after 2003 and became
more effective with the introduction of LLINs [12, 46] for malaria control. A Sahelian drought
in neighbouring countries resulted in a significant reduction in rainfall in the Gambia that
probably affected mosquito numbers and LF transmission in the late 1960s and 1970s [6, 21].
Nevertheless LF was still highly endemic in the Western and Upper River divisions during the
late 1970s [6, 21].
The vectors of malaria in The Gambia are also involved in the transmission of LF with
Anopheles arabiensis, An. gambiae s.s., An.melas and An. funestus acting as the principal carri-
ers ofW. bancrofti. Culexmosquitoes probably play no role in the transmission of LF in The
Gambia as is the case in other countries in West Africa where only Anophelesmosquitoes act
as vectors ofW. bancrofti. Despite the early elucidation of the biology and behaviour of Anoph-
elesmosquitoes in The Gambia, there were no systematic vector control activities in the
Table 1. The changing pattern of LF infection rates determined by night blood and ICT surveys across the 6 administrative divisions in The Gam-
bia between 1951 and 2013.
Year Administrative Division Age group
examined
Survey type
and number of
sampling sites
Site speciﬁc
infection rate
Notes References
#
1951–
1954
Western All age
groups
Night blood
surveys in 4
villages
36–50% 1951 survey in area hyperendemic for
malaria. No infections found in children
younger than 4.5 years. 1954 survey also
failed to detect mf in children <4 years.
4, 19–21,30–
31
1974–
1976
Western, Central, and
Upper River
3 years Night blood
surveys in 15
villages
1.5% ( 3 yrs),
6.7–22.7% ( 5
yrs), 2.9–26.9%
( 15 yrs)
Night blood surveys 21
1997–
2000
North Bank, Upper River
and Western
12 years ICT surveys on
samples from 3
villages
0–8% ICT tests performed on stored serum
samples collected for a malaria project.
Current
study
2003 Banjul, Central, Lower
River, North Bank, Upper
River and Western
15 years ICT mapping
surveys in 30
villages
0–3% Mapping survey carried out in
collaboration with the Ministry of Health
and Social Welfare, Gambia.
Current
study
2013 Banjul, Central, Lower
River, North Bank, Upper
River and Western
6–7 years ICT TAS surveys
in 60 schools
0% Transmission assessment survey
conducted in collaboration with the
Ministry of Health and Social Welfare,
Gambia
Current
study
doi:10.1371/journal.pntd.0003642.t001
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country until insecticide treated bednets were introduced in the 1990s [21]. The report of the
Liverpool School of Tropical Medicine expedition to The Gambia in 1901 recommended mea-
sures to prevent mosquito breeding in the capital, Bathurst [47]. In 1904, an ordinance cover-
ing the prevention of mosquito breeding and establishing posts for a sanitary inspector and a
team of labourers to implement vector control was introduced. However, outside Bathurst no
systematic attempts were made to control mosquitoes until insecticide treated bednets were in-
troduced in the 1990s and scaled up gradually [47]. The main vectors of LF in the Gambia, are
highly susceptible to insecticidal nets and indoor residual spray (IRS). The use of IRS to control
malaria in the 1970s and 1980s interrupted LF transmission in Solomon Islands, parts of Papua
New Guinea, Indonesia and Togo [3]. Community-wide use of long lasting insecticidal nets re-
cently interrupted the transmission of LF in parts of Nigeria[48] and Papua New Guinea [49].
Improvements in living standards and housing characteristics probably contributed to the
elimination of LF in Seychelles, Cape Verde, and Mauritius where Culexmosquitoes were the
main vectors [50]. There is however little evidence that improvement in living standards have
significantly impacted LF transmission in rural areas in Sierra Leone where LF was endemic in
all districts before MDA commenced in 1998 [51].
Knight [21] who performed MF surveys in 1975 and 1976 attributed the decline in MF rates
between 1950 and 1976 to a reduction in human-mosquito contact rates through decreased
rainfall, improved standard of living and vector control against malaria and nuisance mosqui-
toes through bednets,at that time not impregnated with insecticide. Vector control in the form
of IRS with DDT conducted during the malaria eradication campaign in Solomon Islands from
1974 to 1977 decreased the MF prevalence from 22% to zero without the use of anti-filarial
drugs over a period of four years [17, 18].
As a result of Global Fund and PMI funding for bednet implementation, a rapid scale up in
ITN coverage has occurred in many countries in Africa since 2003 when only Eritrea, Malawi,
The Gambia, and Sao Tome and Principe had ITN ownership coverage greater than 20%[12].
Analysing data from suppliers of ITN to countries, National Malaria Control Program
(NMCP) reports of ITNs distributed to health facilities and implementation partners and
household survey data, Flaxman and co-workers[12] calculated insecticidal net ownership cov-
erage for 44 countries in Africa between 2003 and 2008. By the middle of 2008, 8 countries in-
cluding The Gambia had ITN ownership coverage of 60% or greater. There were substantial
increases from 2003 in the delivery of interventions against malaria, including distribution of
insecticidal nets, in The Gambia [52]. Investigating the changes in malaria indices in the coun-
try, and the causes and public-health significance of these changes, Ceesay and collaborators
[13] reported that the proportions of malaria-positive slides decreased by 82% and concluded
that a large proportion of the malaria burden has been alleviated in The Gambia. This remark-
able reduction in malaria parasite positive individuals would confirm our views given that ma-
laria andW.bancrofti have common Anopheles vectors, the absence of any detectableW.
bancrofti in our sample of over 3000 children throughout the country is similarly due to the
widespread use of insecticide impregnated nets and now LLINs.
Previous trials of chemoprophylaxis and insecticidal nets against malaria in The Gambia
have shown reductions in all-cause morbidity and mortality greater than that directly attribut-
able to malaria [13]. Improved treatment against malaria contributed to the reduction in ma-
laria transmission but according to Ceesay and colleagues [13] the most significant factor was
the increase of coverage of insecticidal nets because of support from the Global Fund—awarded
in 2003 and implemented from 2004 onwards—for free distribution of ITNs to pregnant
women and mothers of children younger than 5 years, which according to Ceesay and co-
workers accounted for 55% of the population. A nationwide survey carried out to investigate
the use of ITNs in rural areas of the Gambia in 1991, showed that 58% of beds had a net [46].
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Bednet usage was higher in the Central Region (76%), than in the Western and Eastern Regions
(both 51%)[46]. This could partly explain the difference in LF endemicity between the Central
and Western divisions observed during this study.
In Kenya, one of the few African countries where the coverage of insecticidal nets exceeded
40% in 2007[12], LF prevalence continued to decrease even when MDA was interrupted for
two years [53]. In Sierra Leone, where bednet usage was traditionally low [54] and scaling up of
insecticide-treated nets was among the slowest in Africa [12], LF remains endemic in many
parts of the country after 10 years of MDA with ivermectin for onchocerciasis and more recent-
ly for LF [45, 55]. Onchocerciasis is not endemic in The Gambia and hence mass treatment
with the ivermectin has never been implemented [45]. Comprehensive reviews on the advances
in knowledge of vector ecology, vector-parasite relationships, and both empirical and theoreti-
cal evidence regarding vector management to determine the role of vector control in the
GPELF have concluded that MDA activities can be synergised with vector control and LF elim-
ination will be easier to achieve [3, 7, 14, 15, 56]. Recent studies on the impact of insecticide
treated nets on LF transmission in PNG [49] and Nigeria[48, 57] showed that using insecticidal
nets alone in the absence of MDA interrupted the transmission of LF in highly endemic areas
with MF rates over 50%.
Failure to find evidence of transmission to children ofW. bancrofti in The Gambia in
2013 over a 6–7 year period suggests that transmission has been interrupted and the most
likely cause was the extensive use of insecticide treated nets for malaria control over the last
two decades built upon the causes of the decline observed [17] between the 1950 and 1970s.
The growing evidence for the impact of malaria vector control activities on LF transmission
was endorsed by WHO through a position statement in 2011 on integrated vector manage-
ment (IVM) to control malaria and lymphatic filariasis [58]. IVM is promoted by WHO to
strengthen partnerships and cross sector approaches to the control of mosquito-borne dis-
eases like malaria and LF [15, 58]. In 2014, the Nigerian government converted these evi-
dence based approaches into policy by launching a coordinated plan to eliminate malaria
and lymphatic filariasis through the use of long lasting insecticidal nets (http://www.afro.
who.int/en/nigeria/press-materials/item/6286-nigeria-launches-the-malaria-and-lymphatic-
filariasis-co-implementation-guidelines.html). MDA may not be required to achieve elimina-
tion of LF in The Gambia but surveillance processes prescribed for countries during the post
MDA phase, including morbidity management and disability prevention will be necessary, to
acquire a non-endemic status that demands verification. The Gambia achieving non-endem-
ic status for LF will represents huge progress in the global efforts to shrink the filariasis en-
demicity map and demonstrates the value of cross sector approaches in disease control. One
more country will be removed from the list of LF endemic countries and 1.2 million people
will be declared to be no longer at risk for the disease
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